THE COMPARATIVE EFFICACY AND LONG-TERM EFFECT OF CLOZAPINE TREATMENT ON NEUROPSYCHOLOGICAL TEST-PERFORMANCE

被引:232
|
作者
BUCHANAN, RW
HOLSTEIN, C
BREIER, A
机构
[1] Department of Psychiatry, Maryland Psychiatric Research Center, University of Maryland School of Medicine, Baltimore, MD
关键词
SCHIZOPHRENIA; NEUROPSYCHOLOGICAL TESTING; CLOZAPINE; NEGATIVE SYMPTOMS; POSITIVE SYMPTOMS; QUALITY OF LIFE;
D O I
10.1016/0006-3223(94)90082-5
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Previous studies have suggested that clozapine may improve neuropsychological test performance. The current study was designed to examine the comparative efficacy and the long-term effect of clozapine (versus haloperidol), on neuropsychological test performance. Neuropsychological measures of executive/attention, visuospatial, and memory function were administered to schizophrenic patients at baseline, at the end of a 10-week double-blind study, and after 1 year of open clozapine treatment. Symptoms and function ratings were obtained at the same time points. The 10-week double-blind study revealed significant group-by-time interactions for two measures: Categorical Fluency and WAIS-R Block Design. At the end of 1 year of open treatment there were significant improvements in Verbal Fluency, Mooney Faces Closure, and WAIS-R Block Design performance, and trend improvements in Stroop Color-Word Interference, Category Fluency, and WMS-R Logical Memory performance. Improvements in neuropsychological performance were unrelated to symptom changes. Change in selected neuropsychological measures were significantly correlated with improvement in quality of life. The results suggest that long-term clozapine treatment may have beneficial effects on a broad range of cognitive functions.
引用
收藏
页码:717 / 725
页数:9
相关论文
共 50 条
  • [1] NEUROLEPTIC EFFECTS ON NEUROPSYCHOLOGICAL TEST-PERFORMANCE IN SCHIZOPHRENIA
    VERDOUX, H
    MAGNIN, E
    BOURGEOIS, M
    SCHIZOPHRENIA RESEARCH, 1995, 14 (02) : 133 - 139
  • [2] Compulsory treatment with clozapine: A retrospective long-term cohort study
    Schulte, Peter F. J.
    Stienen, Juan J.
    Bogers, Jan
    Cohen, Dan
    van Dijk, Daniel
    Lionarons, Wendell H.
    Sanders, Sophia S.
    Heck, Adolph H.
    INTERNATIONAL JOURNAL OF LAW AND PSYCHIATRY, 2007, 30 (06) : 539 - 545
  • [3] Long-term clinical efficacy of maintenance electroconvulsive therapy in patients with treatment-resistant schizophrenia on clozapine
    Youn, Tak
    Jeong, Seong Hoon
    Kim, Yong Sik
    Chung, In Won
    PSYCHIATRY RESEARCH, 2019, 273 : 759 - 766
  • [4] CLOZAPINE AND TREATMENT-RESISTANT SCHIZOPHRENIC-PATIENTS - A LONG-TERM PROSPECTIVE-STUDY IN 20 PATIENTS
    JALENQUES, I
    COUDERT, AJ
    ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE, 1994, 20 (06): : 767 - 775
  • [5] Long-term clinical experience with clozapine
    Gelly, F
    Chambon, O
    MarieCardine, M
    ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE, 1997, 23 (05): : 385 - 396
  • [6] RELATIONSHIPS BETWEEN MEDICATION TREATMENTS AND NEUROPSYCHOLOGICAL TEST-PERFORMANCE IN SCHIZOPHRENIA
    SWEENEY, JA
    KEILP, JG
    HAAS, GL
    HILL, J
    WEIDEN, PJ
    PSYCHIATRY RESEARCH, 1991, 37 (03) : 297 - 308
  • [7] Sustained long-term improvement with clozapine in schizophrenia
    De Oliveira-Souza, R
    Marrocos, RP
    De Figueiredo, WM
    ARQUIVOS DE NEURO-PSIQUIATRIA, 1999, 57 (01) : 18 - 22
  • [8] Long-term combination treatment with clozapine and filgrastim in patients with clozapine-induced agranulocytosis
    Hägg, S
    Rosenius, S
    Spigset, A
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2003, 18 (03) : 173 - 174
  • [9] Long-Term Outcome of Clozapine in Treatment-Resistant Schizophrenia
    Lee, Myung A.
    Cola, Philip
    Jayathilake, Karu
    Meltzer, Herbert Y.
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2023, 43 (03) : 211 - 219
  • [10] Reduction in hospital stay of chronic schizophrenic patients after long-term clozapine treatment
    Ahn, YM
    Chang, JS
    Kim, Y
    Lee, KY
    Kim, JH
    Kim, SC
    Maeng, SJ
    Kim, YS
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2005, 20 (03) : 157 - 161